Episode 21: AI for Predicting Clinical T...

In Blade Runner Rick Deckard, meets Rachel. She is very beautiful and vulnerable, with a rich life narrative, andemotional depth. However, Rachel is a highly sophisticated, super-realistic android. But nonetheless he falls in love with her. How close are we to this vision of the ... Show More

Under capitalism a company has to make money. But a big problem in medical AI is that few companies are. Most are burning up venture capital and profitability is very hard to achieve. A key reason is that it is extremely difficult to obtain government reimbursement for the use of ... Show More

Under capitalism a company has to make money. Buta big problem in medical AI is that few companies are. Mostare burning up venture capital and profitability is very hard to achieve. A key reason is that it is extremely difficult to obtain government reimbursement for the use of m ... Show More

ALS is a fatal neurological disease that kills motor neurons. Even though it was first described more than 150 years ago, there is no cure, and the few drugs available only dampen the symptoms or slow the progression by a few months. In recent years new drugs have emerged. Howeve ... Show More

A century after its discovery, insulin remain essential in treating diabetes, and has a relatively low production cost, with a vial generally costing less than $6 to make. But those in the US pay on average 10 times more than those in other countries— leading some patients to tak ... Show More

When people were dying from AIDS in the 1980s and 90s, Congress found a way to expedite the drug approval process and saved countless lives. Established in 1992, the Accelerated Approval Program allows the FDA to speed approval of drugs for patients with serious and life-threaten ... Show More

Benjamin Y. Fong is author of the new book Quick Fixes: Drugs in America from Prohibition to the 21st Century Binge, which was just released in July, 2023 by Verso Books. Ben is an honors faculty fellow and associate director of the Center for Work & Democracy at Arizona State Un ... Show More

Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ... Show More

Dialysis is a medical miracle, a treatment that allows people with kidney failure to live when otherwise they would die. It also provides a captive customer for the dialysis industry, which values the steady revenues that come from critically required long-term care that is guara ... Show More

Sam Harris speaks with Dr. Jennifer Mitchell and Dr. Sarah Abedi about recent developments in research on psychedelics. They discuss the history of this research and the war on drugs, recent setbacks in the FDA approval process, MDMA as a treatment for post-traumatic stress disor ... Show More

On Monday, President Donald Trump signed an executive order telling drugmakers to slash the prices of their medicines. Once again, the president showed an amazing nose for interesting questions. Statistically, the U.S. accounts for 4 percent of the world’s population but nearly 5 ... Show More

New developments in actor Matthew Perry’s death are shining a light on the ethics and efficacy of using ketamine as a therapeutic drug. To learn more about the promise and pitfalls of ketamine treatment, CNN’s Chief Medical Correspondent Dr. Sanjay Gupta turns to David Feifel, on ... Show More

With good healthcare becoming harder to find, and afford, more and more people are turning to Telehealth medicine to get their prescriptions. Generally this type of online Doc has been associated with the trendier drugs with sexy promises. From “boner pills” to weight loss drugs, ... Show More